Ulocuplumab
Ulocuplumab (INN; development code MDX-1338) is a monoclonal antibody designed for the treatment of hematologic malignancies.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Ulocuplumab (INN; development code MDX-1338) is a monoclonal antibody designed for the treatment of hematologic malignancies. Ulocuplumab targets CXCR4. This drug was developed by Bristol-Myers Squibb.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1277212319 under CC BY-SA 4.0; modifications have been made.